BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26880388)

  • 1. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    Forbes A; Anoopkumar-Dukie S; Chess-Williams R; McDermott C
    Prostate; 2016 Jun; 76(8):757-66. PubMed ID: 26880388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K; Kyprianou N
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N; Benning CM
    Cancer Res; 2000 Aug; 60(16):4550-5. PubMed ID: 10969806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
    Benning CM; Kyprianou N
    Cancer Res; 2002 Jan; 62(2):597-602. PubMed ID: 11809715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC; Rhee J; Kyprianou N
    Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    Tahmatzopoulos A; Kyprianou N
    Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers.
    Batty M; Pugh R; Rathinam I; Simmonds J; Walker E; Forbes A; Anoopkumar-Dukie S; McDermott CM; Spencer B; Christie D; Chess-Williams R
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N; Chon J; Benning CM
    Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis.
    Liou SF; Lin HH; Liang JC; Chen IJ; Yeh JL
    Toxicology; 2009 Feb; 256(1-2):13-24. PubMed ID: 19056458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway.
    Garrison JB; Kyprianou N
    Cancer Res; 2006 Jan; 66(1):464-72. PubMed ID: 16397262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].
    Liu SJ; Xu KX; Wang XF; Hou SK; Wang YC
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):604-6. PubMed ID: 15265404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.
    Kobayashi S; Tomiyama Y; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
    J Smooth Muscle Res; 2009 Aug; 45(4):187-95. PubMed ID: 19783871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.
    Harris AM; Warner BW; Wilson JM; Becker A; Rowland RG; Conner W; Lane M; Kimbler K; Durbin EB; Baron AT; Kyprianou N
    J Urol; 2007 Nov; 178(5):2176-80. PubMed ID: 17870114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
    Seo KK; Lee MY; Lim SW; Kim SC
    J Korean Med Sci; 1999 Feb; 14(1):69-74. PubMed ID: 10102527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
    Kyprianou N
    J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Pharmacodynamic Uroselectivity of
    Quaresma BMCS; Pimenta AR; Santos da Silva AC; Pupo AS; Romeiro LAS; Silva CLM; Noël F
    J Pharmacol Exp Ther; 2019 Oct; 371(1):106-112. PubMed ID: 31285236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.
    Kyprianou N; Jacobs SC
    Curr Urol Rep; 2000 Aug; 1(2):89-96. PubMed ID: 12084321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic effects and mechanism of prazosin.
    Liao CH; Guh JH; Chueh SC; Yu HJ
    Prostate; 2011 Jun; 71(9):976-84. PubMed ID: 21541974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induction by quinazoline-derived alpha1-blockers in prostate cancer cells: biomolecular implications and clinical relevance.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2007; 11(1):59-64. PubMed ID: 17405349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle.
    Lin SC; Chueh SC; Hsiao CJ; Li TK; Chen TH; Liao CH; Lyu PC; Guh JH
    Neoplasia; 2007 Oct; 9(10):830-9. PubMed ID: 17971903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.